跳至主要内容
临床试验/NCT07487454
NCT07487454尚未招募不适用

Sham-Controlled Rapid-Acting Neuromodulation for Depression

University of California, Davis1 个研究点 分布在 1 个国家目标入组 264 人开始时间: 2026年12月1日最近更新:
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
264
试验地点
1
主要终点
Montgomery-Åsberg Depression Rating Scale (MADRS)

研究概览

简要总结

The goal of this study is to learn whether 5 days of accelerated intermittent theta burst stimulation (iTBS), a rapid form of transcranial magnetic stimulation (TMS), which is a non-invasive procedure that uses magnetic fields to stimulate brain activity, works to treat depression in adults.

The main questions it aims to answer are:

  • Does accelerated iTBS reduce depressive symptoms compared to sham (placebo) stimulation?
  • Are there measurable brain, biological, and digitally measured emotion changes associated with treatment response?

Participants will:

  • Be randomly assigned to receive either active iTBS or sham stimulation
  • Receive 10 stimulation sessions per day for 5 consecutive days (total of 50 sessions)
  • Complete MRI brain scans and EEG recordings before and after treatment
  • Provide blood and saliva samples to measure biological markers
  • Complete depression rating scales and questionnaires at baseline, during treatment, and at follow-up visits
  • Use a secure mobile app to record brief facial and vocal samples during the 5-day treatment and at follow-up visits
  • Return for follow-up visits at 1 week and at 1, 3, 6, and 12 months after treatment

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • English speaking
  • Able to provide informed consent
  • 18-65 years old
  • Meets MDD criteria per the Mini International Neuropsychiatric Interview (MINI)

排除标准

  • Unable to consent (due to medical condition, acute psychosis, substance use, etc)
  • Use of benzodiazepines or medications that would interfere with TMS treatment as per PI discretion
  • Active substance use or severe substance use that in the opinion of the PI would interfere with study participation
  • Untreated, active psychosis
  • Female patient who is breastfeeding, pregnant or who is planning a pregnancy during the study
  • Contraindications to receiving TMS and/or MRI as determined by screening questionnaires
  • Participation in any clinical study with exposure to any investigational treatment or product within the previous 30 days, or plan on concurrent participation in other studies.

研究组 & 干预措施

Active iTBS

Experimental

The active iTBS group will receive 10 hourly intermittent theta burst stimulation (iTBS) sessions per day for 5 consecutive days.

干预措施: intermittent theta burst stimulation (Device)

Sham iTBS

Sham Comparator

Participants assigned to the sham group will receive 10 hourly sham sessions per day for 5 consecutive days.

干预措施: Sham (No Treatment) (Device)

结局指标

主要结局

Montgomery-Åsberg Depression Rating Scale (MADRS)

时间窗: Baseline through study completion, 1 year

Change in depressive symptoms (MADRS scores)

次要结局

  • Change in large-scale brain network connectivity measured by fMRI(Baseline through study completion, 1 year)
  • Change in electroencephalography (EEG) spectral power(Baseline through study completion, 1 year)
  • Change in facial and vocal affective expression(Baseline through study completion, 1 year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验